SCHEMBL10526705

SCHEMBL10526705

CCOc1cccc(C(=O)C[n+]2cc[nH]c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.43
▸ HPGD P15428 4/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ ALOX12 P18054 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ LMNA P02545 4/20 0.43
▸ NR1H4 Q96RI1 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ POLB P06746 1/20 0.42
▸ CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL10528580 0.99 KMT2A (0.43) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL10528532 0.87 MAPT (0.49) KMT2ASMN1; SMN2ALDH1A1MAPTKDM4E
Bromide SCHEMBL10526754 0.86 MAPT (0.51) SMN1; SMN2ALDH1A1MAPTKDM4ELMNA
SCHEMBL10531137 0.80 KMT2A (0.47) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT
Bromide SCHEMBL10529155 0.79 KMT2A (0.49) KMT2AHPGDALDH1A1MAPTKDM4E
SCHEMBL10529180 0.79 KMT2A (0.45) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT
Bromide SCHEMBL10531122 0.78 KMT2A (0.44) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL4394987 0.76 KMT2A (0.54) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL11044058 0.75 HPGD (0.56) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL7913254 0.73 HPGD (0.55) KMT2AHPGDSMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0182533-B1 3-(2-ARYL-2-OXOETHYL)-IMIDAZOLIUM SALTS AS HYPOGLYCEMIC AGENTS ELI LILLY AND COMPANY (US) 1989-09-20 — — EP claimed
Send feedback